| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 57.167.743 $ | +19.834.137 $ | +66,5 % | 7 | 74.012.998 $ | -8.263.139 $ | -34,5 % | 9 | 122.431.484 $ | +88.319.579 $ | +134,3 % | 9 | ||||
| SOLENO THERAPEUTICS INC | SLNO | → 0 | 13.392.000 $ | +5.612.257 $ | +72,1 % | 1 | 7.779.743 $ | -29.568.108 $ | -79,2 % | 1 | 37.347.851 $ | +22.366.395 $ | +149,3 % | 1 | |
| Replimune Group, Inc. | REPL | → 0 | Neutral | 11.664.000 $ | -3.420.000 $ | -22,7 % | 1 | 15.084.000 $ | +10.174.319 $ | +207,2 % | 1 | ||||
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | → 0 | Schwach | 14.980.753 $ | +14.980.753 $ | 1 | |||||||||
| COMPASS Pathways plc | CMPS | → 0 | Neutral | 5.778.850 $ | -1.811.150 $ | -23,9 % | 1 | 7.590.000 $ | -4.856.030 $ | -39,0 % | 1 | 12.446.030 $ | +8.288.030 $ | +199,3 % | 1 |
| AtaiBeckley Inc. | ATAI | → 0 | Schwach | 7.006.599 $ | -5.091.657 $ | -42,1 % | 1 | 12.098.256 $ | +12.098.256 $ | 1 | |||||
| Edgewise Therapeutics, Inc. | EWTX | → 0 | Stark | 11.042.675 $ | +11.042.675 $ | 1 | |||||||||
| Praxis Precision Medicines, Inc. | PRAX | → 0 | Neutral | 10.571.054 $ | +4.711.033 $ | +80,4 % | 1 | 5.860.021 $ | +560.021 $ | +10,6 % | 1 | ||||
| Ascendis Pharma A/S | ASND | → 0 | 10.155.215 $ | +10.155.215 $ | 1 | ||||||||||
| Minerva Neurosciences, Inc. | NERV | → 0 | Neutral | 9.974.388 $ | +3.319.278 $ | +49,9 % | 1 | 6.655.110 $ | +6.655.110 $ | 1 | |||||
| Abivax S.A. | ABVX | → 0 | Schwach | 9.439.850 $ | +9.439.850 $ | 1 | |||||||||
| LENZ Therapeutics, Inc. | LENZ | → 0 | Neutral | 8.168.409 $ | -1.894.359 $ | -18,8 % | 1 | ||||||||
| Inventiva S.A. | IVA | → 0 | Schwach | 6.975.000 $ | +6.975.000 $ | 1 | |||||||||
| Ovid Therapeutics Inc. | OVID | → 0 | Neutral | 6.256.979 $ | +3.347.429 $ | +115,0 % | 1 | ||||||||
| Taysha Gene Therapies, Inc. | TSHA | → 0 | Schwach | 6.206.826 $ | +6.206.826 $ | 1 | |||||||||
| Amylyx Pharmaceuticals, Inc. | AMLX | → 0 | Neutral | 5.944.144 $ | +5.944.144 $ | 1 | |||||||||
| Tarsus Pharmaceuticals, Inc. | TARS | → 0 | Schwach | 5.672.259 $ | +1.465.922 $ | +34,9 % | 1 | ||||||||
| Solid Biosciences Inc. | SLDB | → 0 | Schwach | 5.522.213 $ | +3.189.368 $ | +136,7 % | 1 | ||||||||
| 57.167.743 $ | +19.834.137 $ | +66,5 % | 7 | 74.012.998 $ | -8.263.139 $ | -34,5 % | 9 | 122.431.484 $ | +88.319.579 $ | +134,3 % | 9 | ||||